Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21462502rdf:typepubmed:Citationlld:pubmed
pubmed-article:21462502lifeskim:mentionsumls-concept:C0024794lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0008051lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0206116lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0670896lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:21462502lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:21462502pubmed:issue1lld:pubmed
pubmed-article:21462502pubmed:dateCreated2011-4-4lld:pubmed
pubmed-article:21462502pubmed:abstractTextMicroglial cells were purified from a mixed neuroglia culture prepared from the neonatal chicken brain in vitro, and were infected with the vvMDV YL040920 isolate and an attenuated MDV vaccine strain CVI988/Rispens, respectively. The presence of cytopathic effect (CPE) was examined daily, and the MEQ expression in MDV-infected microglia was detected by immunohistochemistry assay. DNA replication of the MDV meq gene and transcription of the gB gene were determined by real-time quantitative PCR (qPCR) and qRT-PCR, respectively. The transcripts of Toll-like receptor (TLR) mRNA in microglia post MDV infection were quantified by qRT-PCR. The results of this study showed that both vvMDV YL040920 and attenuated vaccine strain CVI988/Rispens could infect microglia and produce characteristic CPE with plaque formation. The plaques were formed due to cells shedding at multi-sites, then quickly expanded and integrated. Furthermore, the MEQ protein was detected in nuclei of YL040920 and CVI988/ Rispens-infected microglia, and MDV meq DNA replication and gB gene transcription in MDV-infected microglia were also confirmed. Although both MDV DNA copies and gB transcripts were increased in the virus-infected microglia, the higher viral DNA load and gB transcript were observed for CVI988/Rispens than for YL040920 in vitro (P < or = 0.05/0.001). The transcriptions of TLR15 and TLR1LB gene were found to be up-regulated in microglia following MDV infection in vitro. Purified microglia infected with YL040920 was observed increased TLR15 and TLR1LB transcripts as early as 1 day post infection (dpi), and reached its peak level at 3 dpi, then decreased mildly at 5 dpi. For CVI988/Rispens, it induced an increase of TLR15 transcript as early as 1 dpi, and rose rapidly at 3 dpi, and then decreased slightly at 5 dpi. At the same time, CVI988/Rispens induced the increase of chTLR1LB transcript at 3 dpi and decreased at 5 dpi. By comparing the TLRs transcription between YL040920 and CVI988/Rispens-infected microglia, it was suggested that vvMDV YL040920 might induce more TLR15 transcript than the attenuated vaccine strain CVI988/Rispens (P < or = 0.01/0.001), while CVI988/Rispens induced more TLR1LB transcript than YL040920 (P < or = 0.001).lld:pubmed
pubmed-article:21462502pubmed:languagechilld:pubmed
pubmed-article:21462502pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21462502pubmed:citationSubsetIMlld:pubmed
pubmed-article:21462502pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21462502pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21462502pubmed:statusMEDLINElld:pubmed
pubmed-article:21462502pubmed:monthJanlld:pubmed
pubmed-article:21462502pubmed:issn1000-8721lld:pubmed
pubmed-article:21462502pubmed:authorpubmed-author:ChenHaoHlld:pubmed
pubmed-article:21462502pubmed:authorpubmed-author:WeiPingPlld:pubmed
pubmed-article:21462502pubmed:authorpubmed-author:YangQing-liQLlld:pubmed
pubmed-article:21462502pubmed:issnTypePrintlld:pubmed
pubmed-article:21462502pubmed:volume27lld:pubmed
pubmed-article:21462502pubmed:ownerNLMlld:pubmed
pubmed-article:21462502pubmed:authorsCompleteYlld:pubmed
pubmed-article:21462502pubmed:pagination18-25lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:meshHeadingpubmed-meshheading:21462502...lld:pubmed
pubmed-article:21462502pubmed:year2011lld:pubmed
pubmed-article:21462502pubmed:articleTitle[Marek's disease virus can infect chicken brain microglia and promote the transcription of toll-like receptor 15 and 1LB genes].lld:pubmed
pubmed-article:21462502pubmed:affiliationGuangxi University, Nanning 530005. eyangql@sina.comlld:pubmed
pubmed-article:21462502pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21462502pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:21462502pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:421219entrezgene:pubmedpubmed-article:21462502lld:entrezgene
entrez-gene:771173entrezgene:pubmedpubmed-article:21462502lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21462502lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21462502lld:entrezgene